Genfit S.A. (GNFTF)
USD 5.55
(0.0%)
USD 5.55
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 28.22 Million EUR | 32.1% |
| 2022 | 21.36 Million USD | -76.48% |
| 2021 | 90.84 Million USD | 12276.94% |
| 2020 | 734.01 Thousand USD | -98.32% |
| 2019 | 43.71 Million USD | 55317.57% |
| 2018 | 78.87 Thousand USD | -44.33% |
| 2017 | 141.69 Thousand USD | -52.7% |
| 2016 | 299.54 Thousand USD | -47.68% |
| 2015 | 572.48 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 28.22 Million EUR | 32.1% |
| 2023 Q2 | 11.48 Million USD | 40.09% |
| 2023 Q1 | 8.19 Million EUR | -32.85% |
| 2023 Q3 | 2.81 Million EUR | -75.46% |
| 2023 Q4 | 14.26 Million EUR | 406.21% |
| 2022 Q4 | 12.2 Million USD | 129.87% |
| 2022 Q3 | 5.31 Million EUR | -16.51% |
| 2022 Q2 | 6.36 Million USD | 0.0% |
| 2022 FY | 21.36 Million USD | -76.48% |
| 2021 Q2 | 13.04 Thousand USD | 0.0% |
| 2021 FY | 90.84 Million USD | 12276.94% |
| 2021 Q4 | 90.99 Million USD | 0.0% |
| 2020 Q2 | 137.02 Thousand USD | 0.0% |
| 2020 FY | 734.01 Thousand USD | -98.32% |
| 2020 Q4 | 786.74 Thousand USD | 0.0% |
| 2019 FY | 43.71 Million USD | 55317.57% |
| 2019 Q2 | 1138.80 USD | 0.0% |
| 2019 Q4 | 34.61 Million USD | 0.0% |
| 2018 FY | 78.87 Thousand USD | -44.33% |
| 2017 FY | 141.69 Thousand USD | -52.7% |
| 2016 FY | 299.54 Thousand USD | -47.68% |
| 2015 FY | 572.48 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -36668.672% |
| CSL Limited | 7.56 Billion USD | 99.627% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -88.173% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -909764.603% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -141.107% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 76.304% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 82747.145% |
| Mesoblast Limited | -35.16 Million USD | 180.255% |
| Marizyme, Inc. | 457.7 Thousand USD | -6066.458% |
| Genus plc | 178.7 Million USD | 84.206% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -6781.133% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 256681.818% |
| ContraFect Corporation | -154 Thousand USD | 18427.273% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 56548.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | -962.29 Thousand USD | 3032.979% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 7383.594% |
| MultiCell Technologies, Inc. | 49.32 USD | -57226177.372% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 29.904% |
| EV Biologics, Inc. | 48.9 Thousand USD | -57617.791% |
| Q BioMed Inc. | -8988.00 USD | 314118.692% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 0.11% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 183087.552% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -40220.0% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 22815.31% |
| SQZ Biotechnologies Company | 9.79 Million USD | -188.176% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 570051.535% |
| Arch Therapeutics, Inc. | -2439.00 USD | 1157295.572% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -42840.604% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -19988.256% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 87.177% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -45257.246% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 29043.24% |
| GB Sciences, Inc. | -624.00 USD | 4523176.923% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 32907.923% |
| argenx SE | 1.1 Billion USD | 97.454% |
| HST Global, Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 13569330.769% |
| Enzolytics Inc. | 30.7 Thousand USD | -91810.903% |
| Resverlogix Corp. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -5750.346% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 209.404% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 36.372% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 2572.38% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 5585.608% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -4471.547% |
| ONE Bio Corp. | 20.12 Million USD | -40.24% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 93.109% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 318799.187% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 33760.509% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 4579.019% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -2756.735% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -193.664% |
| BioStem Technologies, Inc. | 15.42 Million USD | -82.978% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 238579.087% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 58584.428% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -15885.501% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -15885.501% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -1979.663% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 97424.138% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -6171.401% |
| SYBLEU INC | 11.69 Thousand USD | -241213.269% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 8933.609% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -512.5% |
| Bioxytran, Inc. | -8285.00 USD | 340763.85% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 7666.756% |
| Neutra Corp. | 14.33 Thousand USD | -196788.734% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 34519.512% |
| PureTech Health plc | -1.6 Million USD | 1860.699% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 2918.916% |
| IXICO plc | 3.27 Million USD | -763.119% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 4166.859% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 1675.879% |
| CSL Limited | 7.7 Billion USD | 99.634% |
| Cellectis S.A. | 18 Thousand USD | -156700.0% |